Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01439152 |
|---|---|
| Brief Title: | Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. |
| First Submitted : | September 1, 2011 |
| First Submitted that Met QC Criteria : | September 22, 2011 |
| First Posted : | September 23, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 6, 2021 |
| Last Update Posted : | July 9, 2021 |